OpenLB
Open Library of Bioscience
Advanced Search
Future medicinal chemistry
05 01, 2018;10 (9): 979-981.

Advances in extracellular ligand recognition sites on prostanoid receptors.

Yan Li, Anna Xu, Qinglan Ling, Ke-He Ruan
Author Information
  1. Yan Li: The Center for Experimental Therapeutics & Pharmacoinformatics, Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
  2. Anna Xu: The Center for Experimental Therapeutics & Pharmacoinformatics, Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
  3. Qinglan Ling: The Center for Experimental Therapeutics & Pharmacoinformatics, Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
  4. Ke-He Ruan: The Center for Experimental Therapeutics & Pharmacoinformatics, Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
PMID: 29673264 DOI: 10.4155/fmc-2017-0319

Abstract

No abstract text available.

Keywords

3D computational receptor model COX-1 COX-2 EP3 IP TP ligand recognition site prostanoids site-directed mutagenesis

MeSH Term

Animals
Drug Discovery
Humans
Ligands
Prostaglandins
Receptors, Prostaglandin

Chemicals

Ligands
Prostaglandins
Receptors, Prostaglandin
Editorial

Word Cloud

Created with Highcharts 10.0.0ligandrecognitionAdvancesextracellularsitesprostanoidreceptors3DcomputationalreceptormodelCOX-1COX-2EP3IPTPsiteprostanoidssite-directedmutagenesis

Similar Articles

Cited By

No available data.